Precise determination of time to reach viral load set point after acute HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 4, 2012, Pages 448-454

  Huang, Xiaojie ^a   Chen, Hui ^b   Li, Wei ^a   Li, Haiying ^a   Jin, Xia ^c,f   Perelson, Alan S ^d   Fox, Zoe ^e   Zhang, Tong ^a   Xu, Xiaoning ^a   Wu, Hao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d LOS ALAMOS NATIONAL LABORATORY   (United States)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

acute infection; HIV 1; seroconversion; set point; viral load

Indexed keywords

BIOLOGICAL MARKER; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACCURACY; ACUTE DISEASE; ADULT; ARTICLE; CHINESE; COHORT ANALYSIS; DISEASE COURSE; EARLY INTERVENTION; EMPIRICAL RESEARCH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MATHEMATICAL MODEL; PHYSICIAN; PLASMA; PRIORITY JOURNAL; RELIABILITY; STUDY DESIGN; VIRUS LOAD;

ADOLESCENT; ADULT; CHINA; COHORT STUDIES; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MODELS, THEORETICAL; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84870287312     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827146e0     Document Type: Article

References (29)

1. Henrard DR, Phillips JF, Muenz LR, et al. Natural history of HIV-1 cell-free viremia. JAMA. 1995;274:554-558.
2. Ho DD. Viral counts count in HIV infection. Science. 1998;272:1124-1125.
3. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Int Med. 1997;126:946-954. (Pubitemid 27255797)
4. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317:944-947. (Pubitemid 47301321)
5. Buchbinder SP, Mehrotra DV, Duerr A, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the step study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008;372:1881-1893.
6. Schacker T, Collier AC, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection. Ann Int Med. 1996;125:257-264. (Pubitemid 126449269)
7. Pedersen C, Katzenstein T, Nielsen C, et al. Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: relation to CD4 cell count and clinical course of primary infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:93-99.
8. Lavreys L, Baeten JM, Chohan V, et al. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Inf Dis. 2006;42:1333-1339.
9. Katzenstein TL, Pedersen C, Nielsen C, et al. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS. 1996;10:167-173. (Pubitemid 26056009)
10. Vidal C, Garcia F, Romeu J, et al. Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection. AIDS. 1998;12:1285-1289. (Pubitemid 28330720)
11. O'Brien TR, Rosenberg PS, Yellin F, et al. Longitudinal HIV-1 RNA levels in a cohort of homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:155-161.
12. Hubert JB, Burgard M, Dussaix E, et al; the SEROCO Study Group. Natural history of serum HIV-1 RNA levels in 330 patients with a known date of seroconversion. AIDS. 2000;14:123-131. (Pubitemid 30116437)
13. Lyles RH, Muñoz A, Yamashita TE, et al for the Multicenter AIDS Cohort Study. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. J Inf Dis. 2000;181:872-880. (Pubitemid 30194468)
14. Touloumi G, Pantazis N, Babiker AG, et al on behalf of the CASCADE Collaboration. Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. AIDS. 2004;18:1697-1705. (Pubitemid 39095787)
15. Richardson BA, Mbori-Ngacha D, Lavreys L, et al. Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection. J Virol. 2003;77:7120-7123. (Pubitemid 36666906)
16. Farzadegan H, Henrard DR, Kleeberger CA, et al. Virologic and sero-logic markers of rapid progression to AIDS after HIV-1 seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:448-455.
17. Sabin CA, Devereux H, Phillips AN, et al. Course of viral load throughout HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol. 2000;23:172-177. (Pubitemid 30316842)
18. Lin LI-K. A concordance correlation coefficient to evaluate reproducibil-ity. Biometrics. 1989;45:255-268.
19. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;i:307-310. (Pubitemid 16134762)
20. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Meth Med Res. 1999;8:135-160. (Pubitemid 29425900)
21. O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA. 1996;276:105-110.
22. Mei Y, Wang L, Holte SE. A comparison of methods for determining HIV viral set point. Stat Med. 2008;27:121-139. (Pubitemid 351193663)
23. Schacker TW, Hughes JP, Shea T, et al. Biological and virologic characteristics of primary HIV infection. Ann Intern Med. 1998;128:613-620. (Pubitemid 28169637)
24. Benlahrech A, Harris J, Meiser A, et al. Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infection. Proc Natl Acad Sci U S A. 2009;106:19940-19945.
25. Geskus RB, Miedema FA, Goudsmit J, et al. Prediction of residual time to AIDS and death based on markers and cofactors. J Acquir Immune Defic Syndr Hum Retrovirol. 2003;32:514-521. (Pubitemid 36423123)
26. Kaufmann GR, Cunningham P, Kelleher AD, et al. Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group. J Infec Dis. 1998; 178:1812-1815. (Pubitemid 28558161)
27. Achhra AC, Zhou J, Dabis F, et al. Difference in absolute CD4+ count according to CD4 percentage between Asian and White population HIV-infected patients. J AIDS Clin Res. 2010;1:1-4.
28. Bofill M, Janossy G, Lee CA, et al. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol. 1992;88:243-252.
29. Chng WJ, Tan GB, Kuperan P. Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by singleplatform flow cytometry: influence of age, sex, and race and comparison with other published studies. Clin Diagn Lab Immunol. 2004;11:168-173. (Pubitemid 38090672)